CTI BIOPHARMA CORP: accounts_receivable
| Value | {"amount": 1272000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2015-03-31) |
| Status | current |
| Entity | CTI BIOPHARMA CORP |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5ceaf4ae-5375-4b3c-8a41-7891c649a00a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-15-003443 · Open the official SEC filing →Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000891293/accounts-receivable/2015-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5ceaf4ae-5375-4b3c-8a41-7891c649a00a
History
- no predecessors — first report